MONDAY, Oct. 13 (HealthDay News) -- Quick tumor removal and immunotherapy can reverse the progress of a newly recognized neurological disease called anti-NMDA-receptor encephalitis (ANRE), a new study says.
MONDAY, Oct. 13 (HealthDay News) -- Quick tumor removal and immunotherapy can reverse the progress of a newly recognized neurological disease called anti-NMDA-receptor encephalitis (ANRE), a new study says.